| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 2017 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2004 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2002 | 2017 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 1 | 2010 | 2017 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 2010 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.080 | None | 0.875 | 8 | 2 | 1997 | 2018 | ||||||||
|
tryptophan hydroxylase 1 | 0.553 | 0.731 | 3.2E-07 |
|
group | 0.080 | None | 1.000 | 8 | 1 | 2000 | 2012 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2014 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2014 | ||||||||
|
phosphodiesterase 4B | 0.566 | 0.731 | 0.47 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2016 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2001 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
group | 0.070 | None | 1.000 | 7 | 1 | 1999 | 2018 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2001 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.070 | None | 0.857 | 7 | 2 | 2015 | 2019 | ||||||||
|
FKBP prolyl isomerase 4 | 0.532 | 0.769 | 0.16 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2019 | ||||||||
|
microRNA 137 | 0.513 | 0.846 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2013 | 2019 | |||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
group | 0.060 | None | 1.000 | 6 | 1 | 2003 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
group | 0.060 | None | 1.000 | 6 | 3 | 2010 | 2019 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2019 | ||||||||
|
translin associated factor X | 0.760 | 0.192 | 0.49 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2010 | 2018 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2017 | ||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2000 | 2010 | |||||||||
|
neuronal PAS domain protein 3 | 0.729 | 0.269 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2003 | 2017 | ||||||||
|
parvalbumin | 0.547 | 0.692 | 8.7E-02 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2018 |